André Jefremow
Impact in
- Hepatology top 10%
- Hepatocellular Carcinoma Treatment and Prognosis
-
- Inflammatory Bowel Disease
Papers in
-
- Hepatocellular Carcinoma Treatment and Prognosis 5
- Genetics 4
- Inflammatory Bowel Disease 4
- Co-authors
- Markus Friedrich Neurath (11 shared papers)Maximilian J. Waldner (4 shared papers)Clemens F. Neufert (4 shared papers)Christoph Becker (3 shared papers)Michael W. Vieth (3 shared papers)Stefan Rose‐John (2 shared papers)Raja Narayana Atreya (3 shared papers)Stefan J. Wirtz (2 shared papers)
In The Last Decade
André Jefremow
16 papers receiving 474 citations
Peers
Comparison fields: 5 of 62
- Hepatology 108
- Genetics 129
- Oncology 98
- Cancer Research 29
- Immunology 34
Countries citing papers authored by André Jefremow
This map shows the geographic impact of André Jefremow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by André Jefremow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites André Jefremow more than expected).
Fields of papers citing papers by André Jefremow
This network shows the impact of papers produced by André Jefremow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by André Jefremow. The network helps show where André Jefremow may publish in the future.
Co-authors
The 25 scholars most cited alongside André Jefremow, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 150 | |
| 2 | 2013 | 105 | |
| 3 | 2021 | 39 | |
| 4 | 2020 | 33 | |
| 5 | 2022 | 33 | |
| 6 | 2023 | 32 | |
| 7 | 2022 | 27 | |
| 8 | 2023 | 14 | |
| 9 | 2010 | 11 | |
| 10 | 2020 | 11 | |
| 11 | 2024 | 10 | |
| 12 | 2021 | 6 | |
| 13 | 2020 | 5 | |
| 14 | 2021 | 4 | |
| 15 | 2024 | 4 | |
| 16 | 2020 | 3 |
About André Jefremow
André Jefremow is a scholar working on Hepatology, Genetics, Molecular Biology, Biomaterials and Pharmacology, having authored 16 papers that have together received 487 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (5 papers), Inflammatory Bowel Disease (4 papers), Angiogenesis and VEGF in Cancer (2 papers), Inflammatory mediators and NSAID effects (1 paper), TGF-β signaling in diseases (1 paper), COVID-19 Clinical Research Studies (1 paper), Nanoparticle-Based Drug Delivery (1 paper) and Cancer Immunotherapy and Biomarkers (1 paper). The work is most often cited by research in Hepatology (108 citations), Genetics (129 citations), Oncology (98 citations), Cancer Research (29 citations) and Immunology (34 citations). André Jefremow has collaborated with scholars based in Germany, Japan and Italy. Frequent co-authors include Markus Friedrich Neurath, Maximilian J. Waldner, Clemens F. Neufert, Christoph Becker, Michael W. Vieth, Stefan Rose‐John, Raja Narayana Atreya, Stefan J. Wirtz, Benno Weigmann and Florian R. Greten. Their work appears in journals such as Liver Cancer, Journal of Clinical Investigation, The Journal of Cell Biology, ImmunoTargets and Therapy and Frontiers in Cell and Developmental Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.